Cancer Management and Research
Volume 13, 2021 - Issue
Open access
96
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
Yalin Xie1 Department of Oncology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
, Ning Su1 Department of Oncology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
, Wei Zhou2 Department of Pathology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
, An Lei1 Department of Oncology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
, Xiang Li3 Department of Pharmacy, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
, Weiwei Li4 Department of Medical Business, Amoy Diagnostics Co., Ltd., Xiamen, People’s Republic of China
, Zhan Huang4 Department of Medical Business, Amoy Diagnostics Co., Ltd., Xiamen, People’s Republic of China
, Wenchang Cen1 Department of Oncology, Guangzhou Chest Hospital, Guangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
& Jinxing Hu5 Department of Tuberculosis, Guangzhou Chest Hospital, Guangzhou, People’s Republic of China
show all
Pages 7517-7526
|
Published online: 01 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.